Cao, D., Mehran, R., Roumeliotis, A., Chandiramani, R., Blum, M., Goel, R., … Batchelor, W. (2019). TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study. Journal of the American College of Cardiology, 74(13), B402–B402. https://doi.org/10.1016/j.jacc.2019.08.496

Cao, Davide, Roxana Mehran, Anastasios Roumeliotis, Rishi Chandiramani, Moritz Blum, Ridhima Goel, Samantha Sartori, et al. “TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study.” Journal of the American College of Cardiology 74, no. 13 (October 2019): B402–B402. https://doi.org/10.1016/j.jacc.2019.08.496.

Cao D, Mehran R, Roumeliotis A, Chandiramani R, Blum M, Goel R, et al. TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study. Journal of the American College of Cardiology. 2019 Oct;74(13):B402–B402.

Cao, Davide, et al. “TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study.” Journal of the American College of Cardiology, vol. 74, no. 13, Elsevier BV, Oct. 2019, pp. B402–B402. Crossref, doi:10.1016/j.jacc.2019.08.496.

Cao D, Mehran R, Roumeliotis A, Chandiramani R, Blum M, Goel R, Sartori S, Wang J, Othman I, Liberman H, Allocco D, Underwood P, Batchelor W. TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study. Journal of the American College of Cardiology. Elsevier BV; 2019 Oct;74(13):B402–B402.